Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Re mats question, the win was for Qualcomm snapdragon 3, where we are a optional extra. Which may be why it was announced.
It looks like the wins on Snapdragon 4 are not being announced even though we are built in as standard. Paul said these would be announced but do we just collect the money per chip? Or another reason not to announce these.
Paul said in his opinion there will not be many DMS companies in 2-3 years. He then said one, a long pause then said two perhaps.
I imagine he was saying we will be the only DMs/OMS provider to stay independent unless someone has a large chèquebook.
Perhaps tell the rail unions that, drivers on 60 to 100 k. They need shouting at, or sack them all and computerise it.
It was safestocks on the 18 th August who quoted that, plus about the strength of the dollar helping us.
Berenberg in a note this month mentioned that SEE should be a beneficiary of a strong US dollar as a quarter of its earnings are in that currency. In the note it estimates that Seeing Machines is “expected to experience a c8-14% tailwind to sales in the current fiscal year, followed by a 1-4% benefit in FY23”. With US earnings accelerating along with the dollar strength, I’d hope this will be an underestimate.
More contract wins
As if this wasn’t reason enough to be bullish about a share price rise, we’ve yet to hear of significant wins in auto and aftermarket/fleet that my sources have confirmed have been decided in SEE’s favour. I can only assume there is some slight bureaucratic delay in signing off the contracts.
Great list of questions Terry,
Nobody else has reported taking any contracts either, plus Colin said he had information from knowledgeable friends in the industry that we had won a amount but he imagined there was a delay in signing contracts.
Perhaps it’s because of extras to be quoted for or to be seen working.
Obviously always good to ask the questions but he will only answer the ones he can or wants to.
Their broker seems better than ours at promoting seeing machines, worth a read and I expect once bmw is all seeing machines their revenues are not going to look great.
They did seem obsessed that our wins were mainly through Qualcomm, which isn’t true as we have the 3 pillar approach to give different ways to use our tech.
It may not be easy for them raising funds next spring.
Motley fool only do a basic write up I don’t think they do much research so wouldn’t look into RFQ,s that we are waiting to hear about.
It may be that the snapdragon 4 platform that we are in starts in the cars in 2024 so no or low revenues at the moment.
Why we are not being notified is another question.
It’s a good question especially when Qualcomm were stating they only work with the best that’s why using Seeing Machines, plus we are built into snapdragon 4.
What have the manufacturers got go gain by not telling other OEM’s who they are using? I can’t see what they can gain as many on here know who the supplier is.
I can only assume it’s a Seeing Machines policy untill they have got a higher market share.
The share seems to rise just before the xd but then it slowly drops over untill the next XD is approaching. I find it easier to sell and buy back. I make a bit more money.
At least the price needs to rise for them to make money and I imagine they will want a good return , so eventually we will gain also.
As it’s been said many many times the large shareholders will decide the value of the company if anyone thinks about putting in a offer, they will have the final say. It certainly will be many times higher than present.
50p is a great second dividend.
There will be ups and downs but worth holding for dividends alone.
Does anyone have a link with major shAreholders ?
The FT seems to be out of date, I seemed to think it was around 55%, Magna bought 10 million pounds worth at 11p which wouldn’t be 3% to be declared.
I think we’re just missing volume, the news is arriving slowly and should increase the next few months. imho
When they talked about being surprised by Lack of competition in the DMS market, the extras which the OEM’s are demanding make it even harder for them to make a product to sell.
You can see they are a few years behind us, widening the moat at was stated by Colin.
It just makes our percentage higher as the contracts are signed.
It’s a very quiet board, any views on this share?
I picked a few up after the last trading update, it was a hold in my sipp I’m guessing it’s a watch and wait.
I would imagine that europe should be a good market.
I live in France and you get 70% cover from working then a top up to pay for most of the other 30% for any medical costs. The main thing is the treatment is excellent, once you see a doctor with a problem you normally get a hospital appointment either the same day if needed but certainly within 2-3 weeks.
I just imagine they would jump at anything that makes there job easier with better results, unlike the NHS you get great treatment quickly, really everyone visiting the doctor or hospital should have to pay something.
Thankyou,
Hi, I would assume that even without FDA approval of or other cancer types the hospitals could still use the tests to capture the CTC , as this will prove cost effective.
Someone mentioned a telegram site, is there a link? Or how do I find it please.
The short interest is less than £1400.
https://www.safestocks.co.uk/2022/02/22/growing-broker-coverage-for-seeing-machines/
A little extract, considering over 90% margin on the chip perhaps a case to say this is conservative.
Note that in its base case for 2025, Berenberg has sales at A$137m and gross profit at A$84m.
In the blue-sky case, Berenberg has sales at A$225m and gross profit at A$163m.
Personally, I expect upward revisions to this very soon as my base case is 70%